Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment

Juan Carlos Higareda-Almaraz1,2, Juan S Ruiz-Moreno1,3, Jana Klimentova4

  • 1Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany.

BMC Cancer
|August 26, 2016
PubMed
Abstract

Insights

Galectin-7 (Gal-7) is downregulated in cervical cancer, but its re-expression inhibits tumor growth and impacts immune response. This study reveals Gal-7

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Galectin-7 (Gal-7) is downregulated in cervical cancer, potentially linking cancer apoptosis and immune response.
  • Limited understanding exists on how cervical cancer cells adapt to Gal-7 expression changes.

Purpose of the Study:

  • To investigate the role of Galectin-7 (Gal-7) in cervical cancer.
  • To explore the molecular mechanisms and consequences of Gal-7 re-expression in cervical cancer cells and their microenvironment.

Main Methods:

  • Meta-analysis of Gal-7 expression in cervical cancer cohorts.
  • In silico prediction and bisulfite sequencing for epigenetic analysis.
  • Ectopic re-expression of Gal-7 in cervical cancer cell lines (HeLa, SiHa) followed by transcriptome and proteome analysis.
  • Xenotransplantation studies to examine tumor and microenvironment responses.

Main Results:

  • Galectin-7 (Gal-7) was significantly downregulated in cervical cancer.
  • High Gal-7 and low galectin-1 expression correlated with better patient prognosis.
  • Gal-7 re-expression induced apoptosis, inhibited tumor xenograft growth, and modulated gene networks involved in metabolism, morphogenesis, and immune response.
  • Epigenetic analysis revealed de novo methylation in the Gal-7 promoter.

Conclusions:

  • Galectin-7 (Gal-7) re-expression influences molecular networks critical for cervical cancer hallmarks, including metabolism, growth, invasion, and apoptosis evasion.
  • Gal-7 impacts the tumor microenvironment, affecting networks involved in its configuration and immune surveillance.